Search Results
At ASCO 2019, Dr. Hope Rugo presents on results of the SOPHIA breast cancer study
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
Breast cancer highlights from ASCO 2019
ESMO 2019: Dr. Rugo Highlights Progress in Breast Cancer
ASCO 2013: Breast cancer research highlights
Message from Dr Hope Rugo on COVID 19 and Cancer Patients
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive MBC after prior ant...
Breast Cancer: The Next Wave By Dr. Hope Rugo
Dr. Rugo on Rationale for the ELAINE Study in ESR1-Mutated ER+/HER2- Breast Cancer
Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer
Dr. Rugo on 20-Year Span of Breast Cancer Advancements
Debu Tripathy, MD, elaborates on the SOPHIA trial in HER+ metastatic breast cancer
